Part of the renowned Braunwald family of references,
Hypertension: A Companion to Braunwald’s Heart Disease provides today’s clinicians with clear, authoritative guidance on every aspect of managing and treating patients who suffer from hypertensive disorders.
An invaluable resource for cardiologists, endocrinologists, and nephrologists, this one-stop reference covers all the latest developments from basic science to clinical trials and guidelines related to the treatment of common to complex hypertension. Now fully updated from cover to cover, the 4th Edition offers unparalleled coverage of hypertension in an accessible and user-friendly manner.
Features:- Thoroughly covers new treatment guidelines related to recent research and the latest physiologic understanding for a wide range of patients with hypertension and related co-morbidities.
- Includes new chapters on Hypertension in Women, Mineralocorticoid Receptor Antagonists, Exercise and Hypertension, and Telemedicine/Digital Health.
- Contains new or expanded content on epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management.
- Provides new chapter summaries and a new focus on clinical and actionable content using a streamlined, narrative format.
- Covers behavior management and prevention as an integral part of hypertensive and pre-hypertensive treatment plans.
- Highlights combination drug therapies and management of chronic complications of hypertension.
- Offers expert guidance from worldwide experts in cardiology, endocrinology, and nephrology, and integrates the most recent guidelines from leading organizations around the world.
An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud.
Table of Contents:SECTION I: EPIDEMIOLOGY
- 1. General Population and Global Cardiovascular Risk Prediction
- 2. Hypertension in Latin/Hispanic Population
- 3. Hypertension in East Asians and Native Hawaiians
- 4. Hypertension in South Asians
SECTION II: PATHOPHYSIOLOGY
- 5. Pathogenesis of Hypertension
- 6. Genetics of Hypertension
- 7. Inflammation and Immunity in Hypertension
SECTION III: DIAGNOSIS AND EVALUATION
- 8. The Environment and High Blood Pressure
- 9. Office Blood Pressure Measurement
- 10. Home Monitoring of Blood Pressure
- 11. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management
- 12. White Coat and Masked Hypertension
- 13. Renovascular Hypertension and Ischemic Nephropathy
- 14. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States
- 15. Secondary Hypertension: Pheochromocytoma and Paraganglioma
- 16. Secondary Hypertension: Sleep Disturbances including Sleep Apnea
- 17. Hypertension in Children: Diagnosis and Treatment
SECTION IV: RISK STRATIFICATION
- 18. Natural History of Untreated Hypertension
- 19. Isolated Systolic Hypertension
- 20. Assessment of Target Organ Damage
SECTION V: ANTIHYPERTENSIVE THERAPY
- 21. Diet and Blood Pressure
- 22. Diuretics in Hypertension
- 23. Alpha Blockers and Hypertension
- 24. Renin Angiotensin Aldosterone System Blockers
- 25. Calcium Channel Blockers
- 26. Central Sympathetic Agents and Direct Vasodilators
- 27. Use of Combination Therapies
- 28. Devices Therapies
- 29. Alternative Approaches for Lowering Blood Pressure
SECTION VI: HYPERTENSION MANAGEMENT
- 30. Approach to Difficult to Manage Primary Hypertension
- 31. Hypertension in Ischemic Heart Disease
- 32. Heart Failure
- 33. Hypertension and Chronic Kidney Disease
- 34. Transplant Hypertension
- 35. Obesity
- 36. Cerebrovascular Disease
- 37. Diabetes Mellitus
- 38. Dyslipidemia
SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS
- 39. Hypertension in Pregnancy
- 40. Hypertension in Older People
- 41. Hypertension in African Americans
- 42. Baroreceptor Dysfunction/Orthostatic Hypotension
- 43. Resistant Hypertension
- 44. Hypertension and the Perioperative Period
- 45. Aorta and Peripheral Arterial Disease in Hypertension
- 46. Hypertensive Emergencies and Urgencies
SECTION VIII: OUTCOME TRIALS
- 47. Meta-Analyses of Blood Pressure Lowering Trials and the Blood Pressure Lowering Treatment Trialists’ Collaboration
SECTION IX: HYPERTENSION TREATMENT IN THE FUTURE
- 48. Team-Based Care for Hypertension Management
- 49. Understanding and Improving Medication Adherence
SECTION X: GUIDELINES
- 50. Updated AHA/ACC; ESH/ISH
- 51. Putting All Guidelines into Perspective
